Your Health and Safety is our Priority. Learn more about our COVID-19 Safety Protocols

Book an In-Office or Virtual Appointment

FDA Approves New Drug, Olumiant, for Alopecia Areata

FDA Approves New Drug, Olumiant, for Alopecia Areata

The FDA approved a new medication Olumiant for alopecia based on two double-blind, placebo-controlled clinical trials. Dr Suzanne Friedler, FAAD, a dermatologist sees this medication as best for younger and healthier patients.

Related Media